Latest News
Latest News
When Your Malpractice Insurer Investigates You: What to Know
When a patient reports a doctor to a state medical board, they may also sue the doctor for monetary damages in civil court.
Latest News
The Rise of Sham Peer Reviews
Peer reviews initiated for invalid reasons or against competitors are causing concern.
Latest News
On the Road to Care: Travel Nurses Still in Demand
Increased competition and declining wages — pay for travel nurses declined more than 9% from January 2023 to January 2024 — have made travel...
Latest News
The Bad News Behind the Rise in Locum Tenens
The locum tenens paradox is that its successful growth indicates a deteriorating traditional healthcare model.
Conference Coverage
AI-Assisted Colonoscopy Linked to Higher Rate of Benign Lesion Removal
The findings indicate that full adoption of AIAC could result in about 600,000 more colonoscopies in which only benign, nonadenomatous lesions are...
Commentary
On Second Thought: Aspirin for Primary Prevention — What We Really Know
Recommendations vis-à-vis aspirin have evolved at a dizzying pace.
Latest News
Men Wanted: New Efforts to Attract Male Nurses
Male nurses number just 12% of the profession working in clinics and hospitals, up from less than 3% in 1970.
Latest News
Lawmakers Rush to Stave Off Doctor Pay Cuts as Medicare Finalizes 2025 Rates
“Medicare plans to pay us less while costs go up. You don’t have to be an economist to know that is an unsustainable trend, though one that has...
Latest News
Gardasil 9 at 10 Years: Vaccine Protects Against Multiple Cancers
The WHO has predicted that the 21st century may be the last to experience HPV-associated cancers, currently responsible for more than...
Feature
Outpatient CAR T: Safe, Effective, Accessible
'The future of CAR T-cell therapy lies in balancing safety with accessibility,' says expert.
Conference Coverage
ATA: Updates on Risk, Diagnosis, and Treatment of Thyroid Cancer
Researchers compared medical records of adults with type 2 diabetes and moderate cardiovascular risk who were new users of GLP-1 receptor agonists...